In March 2025, the company announced new options for a immediate-to-client presenting of its Wegovy weight loss drug. The company set up a fresh pharmacy, referred to as NovoCare, which might charge customers $499 monthly for access to the drug, fewer than 50 percent the expense of the drug by other pharmaceutical distribution networks.[53]The subs